BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38300021)

  • 1. Cationic solid lipid nanoparticles (SLN) complexed with plasmid DNA enhance prostate cancer cells (PC-3) migration.
    Garcia-Fossa F; de Jesus MB
    Nanotoxicology; 2024 Feb; 18(1):36-54. PubMed ID: 38300021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.
    Vighi E; Montanari M; Hanuskova M; Iannuccelli V; Coppi G; Leo E
    Int J Pharm; 2013 Jan; 440(2):161-9. PubMed ID: 22982257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of the helper lipid dioleoyl-phosphatidylethanolamine in solid lipid nanoparticles inhibits their transfection efficiency.
    de Jesus MB; Radaic A; Hinrichs WL; Ferreira CV; de Paula E; Hoekstra D; Zuhorn IS
    J Biomed Nanotechnol; 2014 Feb; 10(2):355-65. PubMed ID: 24738343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.
    Oner E; Kotmakci M; Baird AM; Gray SG; Debelec Butuner B; Bozkurt E; Kantarci AG; Finn SP
    J Nanobiotechnology; 2021 Mar; 19(1):71. PubMed ID: 33685469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
    Vighi E; Ruozi B; Montanari M; Battini R; Leo E
    Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.
    Minelli R; Occhipinti S; Gigliotti CL; Barrera G; Gasco P; Conti L; Chiocchetti A; Zara GP; Fantozzi R; Giovarelli M; Dianzani U; Dianzani C
    Br J Pharmacol; 2013 Sep; 170(2):233-44. PubMed ID: 23713413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
    Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S
    Gene; 2020 Mar; 730():144264. PubMed ID: 31759982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of Smad2/Smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
    Hatami M; Kouchak M; Kheirollah A; Khorsandi L; Rashidi M
    Biochem Biophys Res Commun; 2023 Jul; 664():69-76. PubMed ID: 37141640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes.
    Tabatt K; Kneuer C; Sameti M; Olbrich C; Müller RH; Lehr CM; Bakowsky U
    J Control Release; 2004 Jun; 97(2):321-32. PubMed ID: 15196759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.
    Minelli R; Serpe L; Pettazzoni P; Minero V; Barrera G; Gigliotti C; Mesturini R; Rosa AC; Gasco P; Vivenza N; Muntoni E; Fantozzi R; Dianzani U; Zara GP; Dianzani C
    Br J Pharmacol; 2012 May; 166(2):587-601. PubMed ID: 22049973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, development, and in-vitro/in-vivo evaluation of docetaxel-loaded PEGylated solid lipid nanoparticles in prostate cancer therapy.
    Korake S; Bothiraja C; Pawar A
    Eur J Pharm Biopharm; 2023 Aug; 189():15-27. PubMed ID: 37270157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.
    Limeres MJ; Suñé-Pou M; Prieto-Sánchez S; Moreno-Castro C; Nusblat AD; Hernández-Munain C; Castro GR; Suñé C; Suñé-Negre JM; Cuestas ML
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110533. PubMed ID: 31593829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced
    Kitz J; Lefebvre C; Carlos J; Lowes LE; Allan AL
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer.
    Qin X; Liu L; Li Y; Luo H; Chen H; Weng X
    Technol Cancer Res Treat; 2023; 22():15330338231153618. PubMed ID: 36999196
    [No Abstract]   [Full Text] [Related]  

  • 18. Decapeptide Modified Doxorubicin Loaded Solid Lipid Nanoparticles as Targeted Drug Delivery System against Prostate Cancer.
    De K
    Langmuir; 2021 Nov; 37(45):13194-13207. PubMed ID: 34723562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the interplay between the TGF-β pathway and SLN-mediated transfection: implications for gene delivery efficiency in prostate cancer and non-cancer cells.
    Moraes-Lacerda T; Garcia-Fossa F; de Jesus MBB
    Nanotechnology; 2024 Apr; ():. PubMed ID: 38688253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.